YD Bio Ltd
$5.31
▼
-6.45%
2026-04-21 10:23:01
www.ydesgroup.com
NGM: YDES
Explore YD Bio Ltd stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$382.42 M
Current Price
$5.31
52W High / Low
$31 / $5.12
Stock P/E
—
Book Value
$4.57
Dividend Yield
—
ROCE
-22.15%
ROE
-42.69%
Face Value
—
EPS
$-0.02
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
—
Beta
0.22
Debt / Equity
0.34
Current Ratio
13.18
Quick Ratio
13.04
Forward P/E
—
Price / Sales
865
Enterprise Value
$5.92 M
EV / EBITDA
-4.36
EV / Revenue
11.59
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | NewcelX Ltd. | $2.83 | — | $12.13 M | — | 23.66% | 158.49% | $30.8 / $1.83 | $-11.28 |
| 2. | XBiotech Inc. | $2.51 | — | $78.32 M | — | -39.17% | -28.23% | $3.61 / $2.09 | $4.6 |
| 3. | Palvella Therapeutics, Inc. | $129.33 | — | $1.85 B | — | -80.06% | -92.1% | $151.18 / $20.2 | $2.26 |
| 4. | TransCode Therapeutics, Inc. | $8.88 | — | $8.07 M | — | -334.68% | -17.63% | $22.03 / $6.08 | $1.71 |
| 5. | Traws Pharma, Inc. | $1.39 | — | $14.12 M | — | -185.49% | -10.6% | $3.27 / $0.97 | $0.64 |
| 6. | Entera Bio Ltd. | $1.34 | — | $62.47 M | — | -83.6% | -1.08% | $3.22 / $0.91 | $0.28 |
| 7. | NextCure, Inc. | $11.7 | — | $41.66 M | — | -145.43% | -1.11% | $15.74 / $3.85 | $9.97 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | |
|---|---|---|
| Sales | 0.51 M | 0.35 M |
| Operating Profit | -1.46 M | -0.01 M |
| Net Profit | -1.41 M | 0.01 M |
| EPS in Rs | -0.02 | 0 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | |
|---|---|---|
| Total Assets | 6.86 M | 0.32 M |
| Total Liabilities | 0.27 M | 0.3 M |
| Equity | 6.59 M | 0.02 M |
| Current Assets | 3.47 M | 0.27 M |
| Current Liabilities | 0.26 M | 0.3 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | |
|---|---|---|
| Operating CF | -1.84 M | -0.06 M |
| Investing CF | -2.9 M | -0 M |
| Financing CF | 7.73 M | 0.11 M |
| Free CF | -4.75 M | -0.06 M |
| Capex | -2.91 M | -0 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | |
|---|---|---|
| Revenue Growth % | 45.76% | — |
| Earnings Growth % | -10509.73% | — |
| Profit Margin % | -276.58% | 3.87% |
| Operating Margin % | -286.55% | -2.03% |
| Gross Margin % | 30.44% | 43.83% |
| EBITDA Margin % | -250.99% | 6.35% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.